The role of somatostatin analogs in the management of prostate cancer.
Sinisi
A A
AA
Department of Clinical and Experimental Medicine and Surgery, Endocrine and Medical Andrology Unit, II University, Naples, Italy. antonio.sinisi@unina2.it
Rossi
V
V
Prezioso
D
D
Notaro
A
A
Bellastella
G
G
Panza
N
N
Bellastella
A
A
Pasquali
D
D
D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology / Q000627:therapeutic use*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D008297:Male; D015282:Octreotide / Q000494:pharmacology; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D017481:Receptors, Somatostatin / Q000378:metabolism; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000235:genetics / Q000494:pharmacology / Q000627:therapeutic use; D014407:Tumor Cells, Cultured
D018931:Antineoplastic Agents, Hormonal; D012333:RNA, Messenger; D017481:Receptors, Somatostatin; D013004:Somatostatin; D015282:Octreotide